Hem › Levercancer (hepatocellulärt karcinom) › Texas › San Antonio
Kliniska studier för Levercancer (hepatocellulärt karcinom) i San Antonio, TX
13 studier för Levercancer (hepatocellulärt karcinom) söker deltagare vid platser i och runt San Antonio (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of ZW251 in Participants With Advanced Solid Tumors
RekryterarFas 1
- START San Antonio, San Antonio
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
RekryterarFas 3
- Research Site, San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RekryterarFas 1
- START San Antonio, San Antonio
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
RekryterarFas 1
- START-San Antonio, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
RekryterarFas 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RekryterarFas 1
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RekryterarFas 1
- Clinical Trial Site, San Antonio
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RekryterarFas 1/2
- University of Texas Health Science Center - San Antonio, San Antonio
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
RekryterarObservationsstudie
- Mays Cancer Center, San Antonio
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
RekryterarFas 2
- UT Health San Antonio, San Antonio
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
RekryterarFas 2
- Mays Cancer Center, UT Health San Antonio, San Antonio
Levercancer (hepatocellulärt karcinom)-studier i andra städer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Boston, MA18 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- San Francisco, CA14 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
Andra studier i San Antonio
- Icke-småcellig lungcancer59 studier
- Bröstcancer47 studier
- Kolorektal cancer46 studier
- Metastaserande cancer44 studier
- Cancer (alla typer)41 studier
- Övervikt40 studier
- Typ 2-diabetes37 studier
- Övervikt34 studier
- Äggstockscancer31 studier
- Bukspottkörtelcancer31 studier
- Prostatacancer28 studier
- Endometriecancer27 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.